Real-World Use of Novel P2Y12 Inhibitors in Patients with Acute Myocardial Infarction: A Treatment Paradox.
Beigel R, Iakobishvili Z, Shlomo N, Segev A, Witberg G, Zahger D, Atar S, Alcalai R, Kapeliovich M, Gottlieb S, Goldenberg I, Asher E, Matetzky S.
Beigel R, et al. Among authors: gottlieb s.
Cardiology. 2017;136(1):21-28. doi: 10.1159/000447396. Epub 2016 Aug 23.
Cardiology. 2017.
PMID: 27548273